Mark E Saad - Net Worth and Insider Trading
Mark E Saad Net Worth
The estimated net worth of Mark E Saad is at least $746,585 dollars as of 2024-06-08. Mark E Saad is the Director of Axsome Therapeutics Inc and owns about 10,102 shares of Axsome Therapeutics Inc (AXSM) stock worth over $746,538. Mark E Saad is also the CFO of Plus Therapeutics Inc and owns about 20 shares of Plus Therapeutics Inc (PSTV) stock worth over $47. Details can be seen in Mark E Saad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark E Saad has not made any transactions after 2021-11-17 and currently still holds the listed stock(s).
Transaction Summary of Mark E Saad
Mark E Saad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark E Saad owns 3 companies in total, including Catheter Precision Inc (VTAK) , Axsome Therapeutics Inc (AXSM) , and Plus Therapeutics Inc (PSTV) .
Click here to see the complete history of Mark E Saad’s form 4 insider trades.
Insider Ownership Summary of Mark E Saad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VTAK | Catheter Precision Inc | 2018-09-26 | director |
| AXSM | Axsome Therapeutics Inc | 2021-11-17 | director |
| PSTV | Plus Therapeutics Inc | 2012-03-14 | Chief Financial Officer |
Mark E Saad Latest Holdings Summary
Mark E Saad currently owns a total of 2 stocks. Among these stocks, Mark E Saad owns 10,102 shares of Axsome Therapeutics Inc (AXSM) as of November 17, 2021, with a value of $746,538 and a weighting of 99.99%. Mark E Saad also owns 20 shares of Plus Therapeutics Inc (PSTV) as of March 14, 2012, with a value of $47 and a weighting of 0.01%.
Latest Holdings of Mark E Saad
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | 2021-11-17 | 10,102 | 73.90 | 746,538 |
| PSTV | Plus Therapeutics Inc | 2012-03-14 | 20 | 2.35 | 47 |
Holding Weightings of Mark E Saad
Mark E Saad Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark E Saad has made a total of 1 transactions in Axsome Therapeutics Inc (AXSM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Axsome Therapeutics Inc is the acquisition of 3,300 shares on November 17, 2021, which cost Mark E Saad around $113,916.
According to the SEC Form 4 filings, Mark E Saad has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 1 shares on March 14, 2012, which cost Mark E Saad around $25,500.
Insider Trading History of Mark E Saad
- 1
Mark E Saad Trading Performance
GuruFocus tracks the stock performance after each of Mark E Saad's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark E Saad is -12.22%. GuruFocus also compares Mark E Saad's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark E Saad within 3 months outperforms 2 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark E Saad's insider trading performs compared to the benchmark.
Performance of Mark E Saad
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.63 | | | | | |
| Relative Return to S&P 500(%) | -5.65 | | | | | |
Mark E Saad Ownership Network
Mark E Saad Owned Company Details
What does Catheter Precision Inc do?
Who are the key executives at Catheter Precision Inc?
Mark E Saad is the director of Catheter Precision Inc. Other key executives at Catheter Precision Inc include director & Executive Chairman of Board David A Jenkins , Chief Financial Officer Steven K Passey , and Chief Financial Officer Brian Conn .
Catheter Precision Inc (VTAK) Insider Trades Summary
Over the past 18 months, Mark E Saad made no insider transaction in Catheter Precision Inc (VTAK). Other recent insider transactions involving Catheter Precision Inc (VTAK) include a net purchase of 52,259 shares made by David A Jenkins ,
In summary, during the past 3 months, insiders sold 0 shares of Catheter Precision Inc (VTAK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catheter Precision Inc (VTAK) were sold and 52,259 shares were bought by its insiders, resulting in a net purchase of 52,259 shares.
Catheter Precision Inc (VTAK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catheter Precision Inc Insider Transactions
Mark E Saad Mailing Address
Above is the net worth, insider trading, and ownership report for Mark E Saad. You might contact Mark E Saad via mailing address: C/o Cytori Therapeutics, Inc., 3020 Callan Road, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
